Nippon India Mutual Fund, BlackRock, Societe Generale, Morgan Stanley and others on Friday collectively purchased a ten per cent stake in Sai Life Sciences from US-based asset supervisor TPG for ₹1,505 crore by open market transactions.
Apart from, Axis Mutual Fund (MF), Aditya Birla Solar Life MF, Invesco MF, Norway’s Authorities Pension Fund International, German multinational Allianz’s arm Pimco, Axis Max Life Insurance coverage, HDFC MF, Ghisallo Grasp Fund LP, UTI MF, DSP MF have been among the many consumers of Sai Life Sciences shares.
These entities picked up greater than 2.08 crore fairness shares or 10 per cent stake in Hyderabad-based Sai Life Sciences, as per the block deal knowledge on the BSE.
The transaction, valued at round Rs 1,504.75 crore, was executed at a median worth of Rs 722 apiece.
In the meantime, Nippon India MF picked up 49.86 lakh shares or 2.39 per cent holding in Sai Life Sciences. After the stake purchase, Nippon India MF’s stake within the firm rose to 4.88 per cent from 2.48 per cent.
In the meantime, world asset supervisor TPG by its affiliate TPG Asia VII SF offloaded the equal variety of shares in 25 tranches on the similar worth.
Following the stake sale, TPG’s holding in Sai Life Sciences declined to 14.73 per cent from 24.73 per cent.
Shares of Sai Life Sciences rose 5.03 per cent to shut at ₹765.85 apiece on the BSE.
In December final yr, Sai Life Sciences raised ₹3,043 crore by its preliminary public providing and the shares of the corporate made a stellar debut on the bourses.
Sai Life Sciences supplies end-to-end companies throughout the drug discovery, growth and manufacturing worth chain for small molecule new chemical entities (NCE) to world pharmaceutical innovator firms and biotechnology companies.
Revealed on June 20, 2025
.png?rect=23%2C0%2C676%2C355&w=1200&auto=format%2Ccompress&ogImage=true "Biocon Closes Rs 4,500-Crore QIP At 6% Discount To Last Closing")
